Rituximab treatment in patients with active Graves' orbitopathy: effects on proinflammatory and humoral immune reactions

In active Graves' orbitopathy (GO), proinflammatory cytokines predominate. Circulating thyroid stimulating hormone (TSH)-receptor antibodies (TRAb) have been correlated with GO clinical activity and severity. In preliminary studies rituximab (RTX), an anti-CD 20 monoclonal antibody, has induced...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Vannucchi, G, Campi, I, Bonomi, M, Covelli, D, Dazzi, D, Currò, N, Simonetta, S, Bonara, P, Persani, L, Guastella, C, Wall, J, Beck-Peccoz, P, Salvi, M
Format: Artigo
Idioma:Inglês
Publicat: Blackwell Science Inc 2010
Matèries:
Translational Studies
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2962960/
https://ncbi.nlm.nih.gov/pubmed/20529087
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2249.2010.04191.x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars